Another exosomal mRNA, glypican-1 (GPC1), provided excellent diagnostic performance in differentiating PaCa patients from patients with other pancreatic diseases and from healthy individuals, approaching 100% sensitivity and specificity [140]. This evidence concerns the gene GPC1 and pancreas disorder.